MJN: Catheter, Intravascular Occluding, Temporary
What it covers
A vascular clamp is a surgical instrument used to occlude a blood vessel temporarily.
The identification in 21 CFR 870.4450, vascular clamp. FDA gives MJN no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K243795 | pREBOA-PRO Catheter | Prytime Medical Devices, Inc. | Sep 5, 2025 | Traditional |
| K251358 | Bridge Plus Occlusion Balloon (590-002) | Philips Image Guided Therapy Devices | Jun 24, 2025 | Traditional |
| K221294 | preCARDIA Occlusion System | Abiomed, Inc. | Jun 30, 2023 | Traditional |
| K214060 | LANDMARK REBOA Catheter | Zien Medical Technologies, Inc. | Sep 19, 2022 | Traditional |
| K211610 | Fogarty Occlusion Catheter | Edwards Lifesciences, LLC | Feb 14, 2022 | Traditional |
| K212324 | RenovoCath | Renovorx, Inc. | Aug 23, 2021 | Special |
| K210602 | AortaSTAT Occlusion Device | Renalpro Medical, Inc. | Jul 9, 2021 | Traditional |
| K210358 | Neurescue device | Neurescue Aps | May 21, 2021 | Traditional |
| K201652 | COBRA-OS Kit | Front Line Medical Technologies, Inc. | Feb 22, 2021 | Traditional |
| K203540 | Bridge Occlusion Balloon | Spectranetics, Inc. | Dec 23, 2020 | Special |
Clearances by year
41 MJN 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 2 | 162 |
| 2023 | 1 | 422 |
| 2022 | 2 | 266 |
| 2021 | 4 | 116 |
| 2020 | 4 | 64 |
| 2019 | 3 | 117 |
| 2018 | 3 | 63 |
| 2017 | 3 | 54 |
| 2016 | 3 | 110 |
| 2015 | 4 | 245 |
| 2014 | 2 | 170 |
| 2013 | 4 | 87 |
| 2012 | 2 | 41 |
| 2011 | 4 | 69 |
Who submits
24 applicants cleared a MJN device since 2011. 95% of the clearances went to applicants in United States, then Canada (2%) and Denmark (2%). By type: Traditional 78% and Special 22%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Prytime Medical Devices, Inc. | 5 |
| Renovorx, Inc. | 4 |
| LeMaitre Vascular, Inc. | 3 |
| MicroVention, Inc. | 3 |
| NuMED, Inc. | 3 |
| Boston Scientific Corp | 2 |
| Edwards Lifesciences, LLC | 2 |
| Embolx, Inc. | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.4450.
Standards
21 CFR 870.4450 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MJN clearances declared.
Ask about MJN
Questions about MJN
What is FDA product code MJN?
Product code MJN, “Catheter, Intravascular Occluding, Temporary” in FDA's classification database, is a Class II device type under 21 CFR 870.4450 (vascular clamp), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 90 clearances under MJN, 41 of them since 2011.
How many 510(k) clearances are there under MJN?
FDA’s 510(k) database listed 90 clearances under MJN as of Oct 29, 2026, 41 of them decided since 2011; the most recent decision was Sep 5, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a MJN 510(k)?
For the 2 MJN clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 162 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MJN clearances?
Since 2011: Prytime Medical Devices, Inc. (5), Renovorx, Inc. (4), LeMaitre Vascular, Inc. (3), MicroVention, Inc. (3) and NuMED, Inc. (3). 24 applicants have cleared a MJN device in that time.